To all our CKB CORE users, don’t miss the latest new features now available! Register for a free CORE account here and then login for access. Feel free to contact us at ckbsupport@genomenon.com if you have any questions!

Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04782687
Title Phase II Study of Selinexor Plus DRd for Newly Diagnosed Multiple Myeloma
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors US Oncology Research
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Arizona Oncology Associates, PC - HOPE Tucson Arizona 85711 United States Details
Rocky Mountain Cancer Centers Denver Colorado 80218 United States Details
Maryland Oncology Hematology, P.A. Columbia Maryland 21044 United States Details
New York Oncology Hematology, P.C. Albany New York 12206 United States Details
Willamette Valley Cancer Institute and Research Center Eugene Oregon 97401 United States Details
Texas Oncology, P.A. Austin Texas 78705 United States Details
Texas Oncology, P.A. Fort Worth Texas 76104 United States Details
Texas Oncology, P.A. San Antonio Texas 78240 United States Details
Texas Oncology, P.A. Tyler Texas 75702 United States Details
Virginia Cancer Specialists, PC Gainesville Virginia 20155 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field